Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801827 · ClinicalTrials.gov registry record · Phase 1
PET Imaging and Bariatric Surgery
A Phase 1 study of Obesity, Morbid, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00801827 is a Phase 1 study of Obesity, Morbid that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 7 participants, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00801827, a Phase 1 study of Obesity, Morbid, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2/3) and other studies have shown that obese people have less of these. We propose that low DRD2/3 availability seen in morbidly obese subjects will change with weight loss associated with bariatric surgery.
Conditions Studied
Interventions
- DRUG F-18 (fallypride)
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00801827
The ClinicalTrials.gov registry entry for NCT00801827 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (93% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity, Morbid appearing as the primary indexed condition, and to 1 intervention - of which F-18 (fallypride) is the first listed.
NCT00801827 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00801827 about?
NCT00801827 is a clinical study titled "PET Imaging and Bariatric Surgery". The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2/3) and other studies have shown that obese people have less of these. We propose that low DRD2/3 availability seen ...
What is the current status of trial NCT00801827?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2007-01. Estimated completion is 2012-06.
What conditions does trial NCT00801827 study?
This clinical trial studies the following conditions: Obesity, Morbid.
What interventions are being tested in trial NCT00801827?
The interventions under investigation include: F-18 (fallypride) (DRUG).
Who is sponsoring clinical trial NCT00801827?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801827 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Morbid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
RECRUITING
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Time-restricted Eating Among Pregnant Females With Severe Obesity
RECRUITING · NA
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
RECRUITING
-
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.